![Jeffrey Riley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeffrey Riley
Direktor/Vorstandsmitglied bei
GAIN THERAPEUTICS, INC.
Vermögen: 60 900 $ am 30.06.2026
Profil
Jeffrey Lucero Riley was the founder of 526 Ventures LLC, founded in 2009, where the title held was Partner from 2009 to 2012.
Current jobs include Managing Director at Black Crow Ventures LLC since 2009, Independent Director at GT Gain Therapeutics SA since 2019, and Independent Director at Gain Therapeutics, Inc. since 2019.
Former jobs include President, Chief Executive Officer & Director at Theriva Biologics, Inc. from 2012 to 2017, Chief Executive Officer & Director at BlinkTBI, Inc., Chief Financial Officer & VP-Corporate Development at Nichols Institute Diagnostics, Vice President-Finance & Corporate Development at Amphora Discovery Corp.
from 2009 to 2010, President at Telesso Technologies Ltd. in 2009, and Venture Partner at Queensland BioCapital Funds Pty Ltd. Education history includes undergraduate studies at Boise State University and an MBA from Thunderbird School of Global Management.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
GAIN THERAPEUTICS, INC. 0,07 % | 15.07.2026 | 30.000 ( 0,07 % ) | 60 900 $ | 30.06.2026 |
Aktive Positionen von Jeffrey Riley
| Unternehmen | Position | Beginn |
|---|---|---|
| GAIN THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 01.05.2019 |
Black Crow Ventures LLC | Corporate Officer/Principal | 01.11.2009 |
GT Gain Therapeutics SA
 GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops pharmacological chaperones for the treatment of devastating rare diseases | Direktor/Vorstandsmitglied | 11.09.2019 |
Ehemalige bekannte Positionen von Jeffrey Riley
| Unternehmen | Position | Ende |
|---|---|---|
| THERIVA BIOLOGICS, INC. | Vorstandsvorsitzender | 05.12.2017 |
526 Ventures LLC | Gründer | 01.01.2012 |
Amphora Discovery Corp.
 Amphora Discovery Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Finanzdirektor/CFO | 24.03.2010 |
| TELESSO TECHNOLOGIES LTD. | Präsident | 30.06.2009 |
BlinkTBI, Inc.
 BlinkTBI, Inc. Packaged SoftwareTechnology Services Develops a technological software platform for neurological conditions | Vorstandsvorsitzender | - |
Ausbildung von Jeffrey Riley
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
43
Beziehungen ersten Grades
12
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 12 |
|---|---|
Nichols Institute Diagnostics
 Nichols Institute Diagnostics Medical/Nursing ServicesHealth Services Nichols Institute Diagnostics engages in manufacturing and marketing immunoassay systems utilizing direct label chemiluminescence and immunoradiometric technology. The company is headquartered in San Clemente, CA. | Health Services |
Amphora Discovery Corp.
Amphora Discovery Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Thunderbird School of Global Management
 Thunderbird School of Global Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telesso Technologies Ltd.
 Telesso Technologies Ltd. Pharmaceuticals: OtherHealth Technology Operates as a biotechnology research and development company | Health Technology |
Boise State University
 Boise State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Theriva Biologics, Inc.
 Theriva Biologics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and distributes drugs for the treatment of neurological diseases | Health Technology |
Queensland BioCapital Funds Pty Ltd.
 Queensland BioCapital Funds Pty Ltd. Investment ManagersFinance QBF invests in Australian companies in the life sciences and biotechnology sectors including drug development, medical devices and information technology for biosciences research. They invest in seed to mezzanine stage, specializing in companies in which QBF has contacts and technical expertise.They provides financing for early stage & expansion capital requirements with an investment size ranging from AUD $5 to AUD$15 million. QBF makes co-investments. | Finance |
Black Crow Ventures LLC | |
526 Ventures LLC | |
BlinkTBI, Inc.
BlinkTBI, Inc. Packaged SoftwareTechnology Services Develops a technological software platform for neurological conditions | Technology Services |
GT Gain Therapeutics SA
GT Gain Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops pharmacological chaperones for the treatment of devastating rare diseases | Health Technology |
Gain Therapeutics, Inc.
 Gain Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company | Health Technology |
